aldrin-transdiol: dieldrin metabolite suggested as active neurotoxic form; RN refers to (1 alpha,2 alpha,3 beta,4 alpha,4a beta,5 alpha,8 alpha,8a beta)-isomer
ID Source | ID |
---|---|
PubMed CID | 121492700 |
MeSH ID | M0049034 |
Synonym |
---|
5,6,7,8,9,9-hexachloro-1,2,3,4,4a,5,8,8a-octahydro-1,4:5,8-dimethanonaphthalene-2,3-diol |
trans-6,7-dihydroxydihydroaldrin |
wl 40549 |
trans-aldrindiol |
1,4:5,8-dimethanonaphthalene-2,3-diol, 5,6,7,8,9,9-hexachloro-1,2,3,4,4a,5,8,8a-octahydro-, stereoisomer |
aldrin-transdiol |
h9afn5yd9r , |
3106-29-4 |
unii-h9afn5yd9r |
aldrindiol, trans- |
wl-40549 |
1,4:5,8-dimethanonaphthalene-2,3-diol, 5,6,7,8,9,9-hexachloro-1,2,3,4,4a,5,8,8a-octahydro-, (1r,2s,3s,4s,4ar,5r,8s,8as)-rel- |
(1s,2s,3r,4s,5s,6s,7r,8r)-1,8,9,10,11,11-hexachlorotetracyclo[6.2.1.13,6.02,7]dodec-9-ene-4,5-diol |
Q27279794 |
DTXSID40953167 |
AKOS040750312 |
Excerpt | Reference | Relevance |
---|---|---|
" The toxicology of dihydrodiol is more complex than what can be deduced solely on the basis of diminished bioavailability of the epoxide precursor, and the increased hydrophilicity associated with the dihydrodiol moiety." | ( Toxicological significance of dihydrodiol metabolites. Hsia, MT, 1982) | 0.26 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (20.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 4 (80.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |